RecruitingNot ApplicableNCT06495736
Application of Rapid On-site Evaluation in Lymph Node Biopsy of Breast Cancer
Sponsor
Yunnan Cancer Hospital
Enrollment
400 participants
Start Date
Feb 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to evaluate the value of rapid on-site evaluation（ROSE） in lymph node biopsy of breast cancer. The main question it aims to answer is:The ROSE technique was applied to breast cancer lymph node biopsy to improve the diagnostic efficiency and accuracy. Participants underwent routine lymph node biopsy, and the test personnel conducted routine disease examination and rose technique evaluation on the removed ly
Eligibility
Sex: FEMALE
Inclusion Criteria2
- Patients had pathologically confirmed primary breast cancer
- Surgical treatment was available
Exclusion Criteria4
- Previous history of surgery on the affected axilla, internal breast or chest
- Pregnant or breastfeeding patients
- Previous radiotherapy or chemotherapy
- Complicated history of other tumors
Interventions
DIAGNOSTIC_TESTExperimental: ROSE technique stain
The ROSE technical group uses Diff-Quick stain for diagnosis
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06495736
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT041190243 locations
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
NCT074780161 location